Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Valvular Heart Disease

Free Subscription 23.05.2022 9 Am J Cardiol 4 Cardiol Young 12 Catheter Cardiovasc Interv 2 Circ Arrhythm Electrophysiol 2 Circ Cardiovasc Interv 1 Circ Cardiovasc Qual Outcomes 2 Circ Heart Fail 4 Eur Heart J 5 Eur J Cardiothorac Surg 1 Heart 1 Int J Cardiol 1 J Am Coll Cardiol 2 J Am Soc Echocardiogr 4 J Card Surg 7 J Thorac Cardiovasc Surg 3 Pediatr Cardiol 1 Semin Thorac Cardiovasc Surg

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. GRANT JK, Rubin P, Chambers S, Dangl M, et al
   Comparison of In-Hospital Outcomes and Readmission Rates of Transcatheter Aortic Valve Implantation in Mixed Aortic Valve Disease Versus Pure Aortic Stenosis.
   Am J Cardiol. 2022 May 10. pii: S0002-9149(22)00404.
   PubMed         Abstract available
   
   
2. MEDRANDA GA, Rogers T, Case BC, Zhang C, et al
   Sex Disparities in Hemodynamics and Outcomes in Patients Who Underwent Contemporary Transcatheter Aortic Valve Implantation.
   Am J Cardiol. 2022 May 9. pii: S0002-9149(22)00336.
   PubMed         Abstract available
   
   
3. ROBERTS WC, Salam YM
   Examination of Operatively-Excised Bioprostheses in the Mitral Valve Position to Determine the Reason for Dysfunction.
   Am J Cardiol. 2022;172:98-106.
   PubMed         Abstract available
   
   
4. BOURQUE C, Reant P, Bernard A, Leroux L, et al
   Comparison of Surgical Ventricular Septal Reduction to Alcohol Septal Ablation Therapy in Patients with Hypertrophic Cardiomyopathy.
   Am J Cardiol. 2022;172:109-114.
   PubMed         Abstract available
   
   
5. MARON MS, Rosing DR, Braunwald E, Rastegar H, et al
   Sixty-Year Evolution of Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy with Insights From the Historic NIH Surgical Experience to Present.
   Am J Cardiol. 2022;172:107-108.
   PubMed        
   
   
6. MAKHDUMI M, Roberts WC
   Combined Cardiovascular Syphilis and Aortic Valve Stenosis (Due to a Congenitally Unicuspid Valve).
   Am J Cardiol. 2022;172:144-145.
   PubMed         Abstract available
   
   
7. MARON MS, Lanuario EL, Rowin EJ, Maron BJ, et al
   Global Dissemination and Implementation of Contemporary Management Principles for Hypertrophic Cardiomyopathy and Role of the International HCM Summit.
   Am J Cardiol. 2022;172:146-149.
   PubMed        
   
   
8. MARON BJ, Maron MS
   Reflections on Six Decades of Hypertrophic Cardiomyopathy From Eugene Braunwald.
   Am J Cardiol. 2022;172:150-153.
   PubMed         Abstract available
   
   
9. MARON BJ, Maron MS
   Jeff Zucker Says Hypertrophic Cardiomyopathy is a Curable Disease: A Patient's Perspective.
   Am J Cardiol. 2022;172:154-156.
   PubMed         Abstract available
   
   

   
   Cardiol Young

10. SADIQ M, Qureshi AU, Younas M, Arshad S, et al
    Percutaneous closure of ventricular septal defect using LifeTech(TM) Konar-MF VSD Occluder: initial and short-term multi-institutional results.
    Cardiol Young. 2022;32:755-761.
    PubMed         Abstract available
    
    
11. ISHIDOU M, Ikai A, Sakamoto K
    Truncal valve leaflet reconstruction with autologous pericardium in a neonate.
    Cardiol Young. 2022;32:818-820.
    PubMed         Abstract available
    
    
12. FOLEY R, Duignan S, McArdle L, Betts DR, et al
    Nicolaides-Baraitser syndrome in a patient with hypertrophic cardiomyopathy and SMARCA2 gene deletion.
    Cardiol Young. 2022;32:821-823.
    PubMed         Abstract available
    
    
13. KAWAMURA J, Ueno K, Kawano Y
    Neonatal Marfan syndrome with missense variant of c.3706T>C undergoing bilateral atrioventricular valve replacement.
    Cardiol Young. 2022;32:833-836.
    PubMed         Abstract available
    
    

    
    Catheter Cardiovasc Interv

14. TANG GHL, Hooda A, Zaid S, Chuang MY, et al
    Outcomes and feasibility of redo-TAVR after Sapien 3 Ultra TAVR in extremely-undersized versus nominally-sized annuli.
    Catheter Cardiovasc Interv. 2022;99:1935-1944.
    PubMed         Abstract available
    
    
15. CORCIONE N, Berni A, Ferraro P, Morello A, et al
    Transcatheter aortic valve implantation with the novel-generation Navitor device: Procedural and early outcomes.
    Catheter Cardiovasc Interv. 2022 May 12. doi: 10.1002/ccd.30179.
    PubMed         Abstract available
    
    
16. VENTURI G, Scarsini R, Pighi M, Kotronias RA, et al
    Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI.
    Catheter Cardiovasc Interv. 2022;99:1925-1934.
    PubMed         Abstract available
    
    
17. ALADIN AI, Case BC, Wermers JP, Rogers T, et al
    Overview of FDA Circulatory System Devices Panel virtual meeting on TriGUARD 3 cerebral embolic protection.
    Catheter Cardiovasc Interv. 2022;99:1789-1795.
    PubMed         Abstract available
    
    
18. YA'QOUB L, Gad M, Faza NN, Kunkel KJ, et al
    Sex differences in outcomes of transcatheter edge-to-edge repair with MitraClip: A meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1819-1828.
    PubMed         Abstract available
    
    
19. ROTTLANDER D, Beucher H, Ghaddioui KA, Boekstegers P, et al
    Continuous atrial pressure monitoring via steerable guide catheter in transcatheter mitral and tricuspid edge-to-edge repair.
    Catheter Cardiovasc Interv. 2022;99:1796-1806.
    PubMed         Abstract available
    
    
20. PORAT A, Gordon M, Perlman G, Planer D, et al
    Mass to voltage ratio index predicts mortality following TAVI.
    Catheter Cardiovasc Interv. 2022;99:1918-1924.
    PubMed         Abstract available
    
    
21. MOHANTY BD, Coylewright M, Sequeira AR, Shin D, et al
    Characteristics and clinical outcomes in patients with prior chest radiation undergoing TAVR: Observations from PARTNER-2.
    Catheter Cardiovasc Interv. 2022;99:1877-1885.
    PubMed         Abstract available
    
    
22. SEDHOM R, Megaly M, Saad M, Elbadawi A, et al
    Transcatheter edge-to-edge repair of the tricuspid valve: The US experience.
    Catheter Cardiovasc Interv. 2022;99:1859-1866.
    PubMed         Abstract available
    
    
23. TARANTINI G, Cardaioli F
    TAVR and stroke: A common evolution.
    Catheter Cardiovasc Interv. 2022;99:1906-1907.
    PubMed        
    
    
24. POSTALIAN A, Krajcer Z
    Mitral annular calcification-A marker of risk, and a harbinger of technical challenges during intervention.
    Catheter Cardiovasc Interv. 2022;99:1817-1818.
    PubMed        
    
    
25. TANG GHL, Dangas GD
    Tailoring the therapy to the patient with mitral and tricuspid regurgitation to avoid adverse long-term outcomes.
    Catheter Cardiovasc Interv. 2022;99:1857-1858.
    PubMed        
    
    

    
    Circ Arrhythm Electrophysiol

26. KOHLI U, Saarel EV, Shah M
    Extreme Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: Good News or Bad News?
    Circ Arrhythm Electrophysiol. 2022;15:e011033.
    PubMed        
    
    
27. NORRISH G, Ding T, Field E, Cervi E, et al
    Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy.
    Circ Arrhythm Electrophysiol. 2022;15:e010075.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Interv

28. INCI EK, Greenbaum AB, Lederman RJ, Kohli K, et al
    Transcatheter Electrosurgical Laceration and Stabilization of Failed MitraClip[s]/SAPIEN M3 for Treatment of Failed MitraClip.
    Circ Cardiovasc Interv. 2022;15:e012014.
    PubMed        
    
    
29. EL-SABROUT H, Ganta S, Guyon P, Ratnayaka K, et al
    Neonatal Myocardial Infarction: A Proposed Algorithm for Coronary Arterial Thrombus Management.
    Circ Cardiovasc Interv. 2022 Apr 29:101161CIRCINTERVENTIONS121011664.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Qual Outcomes

30. GUDUGUNTLA V, Yaser JM, Keteyian SJ, Pagani FD, et al
    Variation in Cardiac Rehabilitation Participation During Aortic Valve Replacement Episodes of Care.
    Circ Cardiovasc Qual Outcomes. 2022 May 13. doi: 10.1161/CIRCOUTCOMES.122.009175
    PubMed         Abstract available
    
    

    
    Circ Heart Fail

31. FALK RH, Dorbala S, Cuddy SAM
    Letter by Falk et al Regarding Article, "False-Positive (99m)Technetium-Pyrophosphate Scintigraphy in Two Patients With Hypertrophic Cardiomyopathy".
    Circ Heart Fail. 2022 Apr 5:101161CIRCHEARTFAILURE121008636.
    PubMed        
    
    
32. SHAH KB, Rao K, Trankle CR
    Response by Shah et al to Letter Regarding Article, "False-Positive (99m)Technetium-Pyrophosphate Scintigraphy in Two Patients With Hypertrophic Cardiomyopathy".
    Circ Heart Fail. 2022 Apr 5:101161CIRCHEARTFAILURE121008697.
    PubMed        
    
    

    
    Eur Heart J

33. COLLET JP, Van Belle E, Thiele H, Berti S, et al
    Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial.
    Eur Heart J. 2022 May 18. pii: 6587401. doi: 10.1093.
    PubMed         Abstract available
    
    
34. 
    Corrigendum to: The new European Society of Cardiology/European Association for Cardio-Thoracic Surgery recommendations for transcatheter aortic valve intervention are too restrictive.
    Eur Heart J. 2022 May 19. pii: 6588540. doi: 10.1093.
    PubMed        
    
    
35. GALIUTO L, Massetti M
    To repair or not to repair: the dilemma of tricuspid regurgitation associated with left-sided valvular heart disease.
    Eur Heart J. 2022;43:1792-1793.
    PubMed        
    
    
36. OECHSLIN L, Corti R, Biaggi P, Gaemperli O, et al
    Percutaneous closure of left ventricular pseudoaneurysm after direct surgical mitral valve implantation of balloon-expandable transcatheter prosthesis in severe mitral annular calcification.
    Eur Heart J. 2022;43:1884.
    PubMed        
    
    

    
    Eur J Cardiothorac Surg

37. LANSAC E, Di Centa I, Danial P, Bouchot O, et al
    Aortic valve repair versus mechanical valve replacement for root aneurysm: The CAVIAAR Multicentric Study.
    Eur J Cardiothorac Surg. 2022 May 18. pii: 6588078. doi: 10.1093.
    PubMed         Abstract available
    
    
38. SALA A
    Isolated tricuspid valve disease: transcatheter treatment "for all"?
    Eur J Cardiothorac Surg. 2022 May 16. pii: 6586290. doi: 10.1093.
    PubMed        
    
    
39. VOGT F, Santarpino G, Fujita B, Frerker C, et al
    Surgical aortic valve replacement in patients aged 50-69 years-insights from the German Aortic Valve Registry (GARY).
    Eur J Cardiothorac Surg. 2022 May 14. pii: 6585867. doi: 10.1093.
    PubMed         Abstract available
    
    
40. KRESOJA KP, Noack T, Lurz P
    Surgical Tricuspid Valve Repair - To 3D or not 3D.
    Eur J Cardiothorac Surg. 2022 May 12. pii: 6584823. doi: 10.1093.
    PubMed        
    
    
41. SQUICCIMARRO E, Margari V, Paparella D
    Bilateral mini-thoracotomy for combined minimally invasive direct coronary artery bypass and mitral valve repair.
    Eur J Cardiothorac Surg. 2022 May 12. pii: 6584819. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Heart

42. LINDMAN BR, Goel K
    British Societies' recommendations for Heart Team multidisciplinary meetings: broadly relevant principles with anticipated regional differences in process.
    Heart. 2022;108:824-826.
    PubMed        
    
    

    
    Int J Cardiol

43. CASTRO-MEJIA AF, Amat-Santos I, Ortega-Armas ME, Baz JA, et al
    Development of atrioventricular and intraventricular conduction disturbances in patients undergoing transcatheter aortic valve replacement with new generation self-expanding valves: A real world multicenter analysis.
    Int J Cardiol. 2022 May 9. pii: S0167-5273(22)00665.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

44. GENEREUX P, Pibarot P, Redfors B, Bax JJ, et al
    Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve Replacement.
    J Am Coll Cardiol. 2022 May 14. pii: S0735-1097(22)04979.
    PubMed         Abstract available
    
    

    
    J Am Soc Echocardiogr

45. NASER JA, Pislaru SV, Pislaru C, Jouni H, et al
    Averaged Transaortic Mean Gradient During Atrial Fibrillation Does Not Accurately Reflect Aortic Stenosis Severity.
    J Am Soc Echocardiogr. 2022 May 10. pii: S0894-7317(22)00244.
    PubMed        
    
    
46. ALTES A, Levy F, Marechaux S
    The Authors' Reply: Awareness of the relationship between sex, body surface area, and the quantification of mitral regurgitant volume in patients with significant primary mitral regurgitation.
    J Am Soc Echocardiogr. 2022 May 9. pii: S0894-7317(22)00242.
    PubMed        
    
    

    
    J Card Surg

47. RIVERA H, Mendoza CE
    Suprasternal transcatheter aortic valve replacement: More positive news on an alternative approach.
    J Card Surg. 2022 May 13. doi: 10.1111/jocs.16602.
    PubMed        
    
    
48. GERDISCH MW
    Coronary artery obstruction during mitral valve surgery and concomitant left atrial appendage exclusion; choosing a culprit.
    J Card Surg. 2022 May 16. doi: 10.1111/jocs.16586.
    PubMed        
    
    
49. KHATRI M
    Aortic valve repair in patients with ventricular septal defect.
    J Card Surg. 2022 May 17. doi: 10.1111/jocs.16600.
    PubMed        
    
    
50. NAKAGAWA Y, Imamura T
    Optimal surgical strategy for those with aortic valve endocarditis and aortic root abscess.
    J Card Surg. 2022 May 19. doi: 10.1111/jocs.16623.
    PubMed        
    
    

    
    J Thorac Cardiovasc Surg

51. KOUCHOUKOS NT
    Commentary: Rapid deployment versus conventional tissue valves ... and the beat goes on.
    J Thorac Cardiovasc Surg. 2022;163:2043-2044.
    PubMed        
    
    
52. BRESCIA AA, Bolling SF, Yang B
    Commentary: Expanded options for dialysis-dependent patients requiring valve replacement in the transcatheter era.
    J Thorac Cardiovasc Surg. 2022;163:2072-2073.
    PubMed        
    
    
53. CATARINO P, Megna D, Chikwe J
    Commentary: The importance of surgical case volume in the transcatheter era.
    J Thorac Cardiovasc Surg. 2022;163:2055-2056.
    PubMed        
    
    
54. DEWEY TM, Herbert MA, Prince SL, Bowers BS, et al
    Influence of surgical volume on outcomes in low-risk patients undergoing isolated surgical aortic valve replacement.
    J Thorac Cardiovasc Surg. 2022;163:2046-2052.
    PubMed         Abstract available
    
    
55. AL-RADI OO
    Commentary: The Everest of pediatric cardiac surgery: Unifocalization of aortopulmonary collateral arteries.
    J Thorac Cardiovasc Surg. 2021 Oct 19. pii: S0022-5223(21)01483.
    PubMed        
    
    
56. MAINWARING RD, Capecci L, Collins RT, Hanley FL, et al
    Midterm fate of unifocalized major aortopulmonary collateral arteries in patients with retroesophageal major aortopulmonary collateral arteries.
    J Thorac Cardiovasc Surg. 2022;163:2175-2181.
    PubMed         Abstract available
    
    
57. PIROLLI TJ
    Commentary: Why "tri" to repair the valve if it will just "lead" to recurrent regurgitation?
    J Thorac Cardiovasc Surg. 2022;163:2196-2197.
    PubMed        
    
    

    
    Pediatr Cardiol

58. DALLDORF K, Parness I, Ezon D
    Juxtaposition of the Atrial Appendages: A Large Echocardiographic Series.
    Pediatr Cardiol. 2022;43:1094-1103.
    PubMed         Abstract available
    
    
59. NAKANISHI K, Kawasaki S, Amano A
    Novel Technique for Tetralogy of Fallot Repair with Transannular Patch Using Pedicled Own Pericardium.
    Pediatr Cardiol. 2022;43:1169-1171.
    PubMed         Abstract available
    
    
60. PRZYBYLSKI R, Fischer IR, Gauvreau K, Alexander ME, et al
    Assessment of Exercise Function in Children and Young Adults with Hypertrophic Cardiomyopathy and Correlation with Transthoracic Echocardiographic Parameters.
    Pediatr Cardiol. 2022;43:1037-1045.
    PubMed         Abstract available
    
    

    
    Semin Thorac Cardiovasc Surg

61. WU DM, Buratto E, Schulz A, Zhu MZL, et al
    Outcomes of mitral valve repair in children with infective endocarditis: a single-center experience.
    Semin Thorac Cardiovasc Surg. 2022 May 17. pii: S1043-0679(22)00121.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: